RxDoctor Payments Data

Robert Billingsley

Psychiatry · Fayetteville, ARNPI 1790846947

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,828 of the $2,461 with a category attached, or 74.3%. Every reported general payment came from a single manufacturer, Neurocrine Biosciences, Inc..

$2,461in general payments, 2019–2025

Across 14 payments — averaging $175.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurocrine Biosciences, Inc.$2K
$5,948,107in research payments, 2019–2025

Across 936 payments — averaging $6354.82 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1.2M
  • Sunovion Pharmaceuticals Inc.$1M
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$718K
  • Vanda Pharmaceuticals Inc.$607K
  • AbbVie$549K
  • Teva Pharmaceuticals USA, Inc.$532K
  • plus $1.3M from 15 others

What the payments were for

  • Travel & lodging$1,82874%
  • Food & beverage$63326%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Neurocrine Biosciences, Inc.14$2,461

How this compares

$2,461 in reported general payments places this provider in the 80th percentile of 235 psychiatry providers in Arkansas.

See all psychiatry providers in Arkansas →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clorazepate Dipotassium12$836
Venlafaxine Hcl ErVenlafaxine Hcl23$346
Clonazepam31$217
Amitriptyline Hcl17$127

Paid to pharmacies, not to this prescriber.

Other psychiatry in Fayetteville

See the full list for Arkansas →

Where these figures come from

Is this you, or does something look wrong? →